{"nct_id":"NCT05228470","title":"A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-04","start_date":"2021-12-21","start_date_type":"ACTUAL","primary_completion_date":"2023-08-06","primary_completion_date_type":"ACTUAL","completion_date":"2025-08-31","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["PFE"]}